Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure

Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T

(2020) Alberto Aimo et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic value of sST2 in patients with heart failure with reduced, mid-range and preserved ejection fraction

(2020) Yu Song et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT‐HF study

(2020) Josip A. Borovac et al.   ESC Heart Failure

Clinical Significance of Brachial-Ankle Pulse Wave Velocity in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction

(2019) Masafumi Takae et al.   AMERICAN JOURNAL OF HYPERTENSION

Coronary artery disease and endothelial dysfunction: Novel diagnostic and therapeutic approaches

(2019) Evangelos Oikonomou et al.   CURRENT MEDICINAL CHEMISTRY

Clinical and Prognostic Significance of sST2 in Heart Failure

(2019) Alberto Aimo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients

(2018) Evangelos Oikonomou et al.   CLINICAL NUTRITION

Pulmonary Production of Soluble ST2 in Heart Failure

(2018) Domingo A. Pascual-Figal et al.   Circulation-Heart Failure

Association of soluble ST2 with functional capacity in outpatients with heart failure

(2017) O. Yucel et al.   HERZ

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

(2017) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction

(2017) Omar F. AbouEzzeddine et al.   Journal of the American Heart Association

Biologic Variability of Soluble ST2 in Patients With Stable Chronic Heart Failure and Implications for Monitoring

(2016) Susan Piper et al.   AMERICAN JOURNAL OF CARDIOLOGY

Variability of biomarkers in patients with chronic heart failure and healthy controls

(2016) Wouter C. Meijers et al.   EUROPEAN JOURNAL OF HEART FAILURE

Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population

(2016) Ravi H. Parikh et al.   Journal of the American Heart Association

Soluble ST2—Analytical Considerations

(2015) Thomas Mueller et al.   AMERICAN JOURNAL OF CARDIOLOGY

Structural Heart Disease and ST2: Cross-Sectional and Longitudinal Associations With Echocardiography

(2015) Christopher deFilippi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

(2015) Humberto Villacorta et al.   Arquivos Brasileiros de Cardiologia

Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients

(2015) Evangelos Oikonomou et al.   ATHEROSCLEROSIS

Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: The BIOCRT study

(2014) Quynh A. Truong et al.   HEART RHYTHM

Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results

(2013) Alan H.B. Wu et al.   AMERICAN HEART JOURNAL

Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure

(2013) Dimitris Tousoulis et al.   ATHEROSCLEROSIS

Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature

(2013) Svitlana Demyanets et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study

(2012) E. E. Coglianese et al.   CLINICAL CHEMISTRY

Endothelial Dysfunction

(2012) Carolyn S.P. Lam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comentarios a la guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología

(2012) Manuel Anguita et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’

(2010)   EUROPEAN HEART JOURNAL

B-Type Natriuretic Peptides and Cardiovascular Risk

(2009) Emanuele Di Angelantonio et al.   CIRCULATION

Comparison of aortic pulse wave velocity measured by three techniques: Complior, SphygmoCor and Arteriograph

(2008) Marek W Rajzer et al.   JOURNAL OF HYPERTENSION

The IL-33/ST2 pathway: therapeutic target and novel biomarker

(2008) Rahul Kakkar et al.   NATURE REVIEWS DRUG DISCOVERY

Biomarkers in Heart Failure

(2008) Eugene Braunwald   NEW ENGLAND JOURNAL OF MEDICINE

Endothelial function and inflammation in coronary artery disease

(2005) D Tousoulis et al.   POSTGRADUATE MEDICAL JOURNAL